Pneumonic vs nonpneumonic acute exacerbations of COPD

Chest

Volumn 122, Issue 4, 2002, Pages 1264-1270

  Lieberman, David ^a,b   Lieberman, Devora ^a   Gelfer, Yevgenia ^a   Varshavsky, Raiesa ^a   Dvoskin, Bella ^a   Leinonen, Maija ^a   Friedman, Maureen G ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

COPD; Exacerbation; Pneumonia, community acquired

Indexed keywords

ANTIBODY;

ADULT; AGED; ANTIBODY TITER; ARTICLE; ARTIFICIAL VENTILATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFECTION; INTENSIVE CARE UNIT; ISRAEL; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; ONSET AGE; OXYGEN TENSION; PARAMETER; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROLOGY; SERUM; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS PNEUMONIAE; VIRUS;

EID: 0036428957     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.122.4.1264     Document Type: Article

References (23)

1. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152:S77-S120
2. Anthonisen NR, Manfreda J, Warren CPW, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106:196-204
3. Marrie TJ, Durant H, Yates L. Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev Infect Dis 1989; 11:586-599
4. Pachon J, Prados MD, Capote F, et al. Severe community-acquired pneumonia: etiology, prognosis and treatment. Am Rev Respir Dis 1990; 142:369-373
5. Torres A, Serra-Batlles J, Ferrer A, et al. Severe community-acquired pneumonia: epidemiology and prognostic factors. Am Rev Respir Dis 1991; 144:312-318
6. Torres A, Dorca J, Zalacain R, et al. Community-acquired pneumonia in chronic obstructive pulmonary disease: a Spanish multicenter study. Am J Respir Crit Care Med 1996; 154:1456-1461
7. Lieberman D, Lieberman D, Ben-Yaakov M, et al. Infectious etiologies in acute exacerbation of COPD. Diagn Microbiol Infect Dis 2001; 40:95-102
8. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows: report of the Working Party for the Standardization of Lung Function Tests, European Community for Steel and Coal; Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16:5-40
9. British Thoracic Society. Guidelines for the management of chronic obstructive pulmonary disease: management of acute exacerbations of COPD. Thorax 1997; 52(suppl 5):S16-S21
10. Calverley PMA, Rennard S, Agusti AGN, et al. Current and future management of acute exacerbations of chronic obstructive pulmonary disease. Eur Respir Rev 1999; 9:193-205
11. Smith JA, Redman P, Woodhead MA. Antibiotic use in patients admitted with acute exacerbations of chronic obstructive pulmonary disease. Eur Respir J 1999; 13:835-838
12. Soler N, Torres A, Ewig S, et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 1998; 157:1498-1505
13. Connors AF Jr, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease: The SUPPORT investigators (Study to Understand Prognosis and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 1996; 154:959-967
14. Brochard L, Mancebo J, Wysocki M, et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1995; 333:817-822
15. Dewan NA, Rafique S, Kanwar B, et al. Acute exacerbation of COPD: factors associated with poor treatment outcome. Chest 2000; 117:662-671
16. Snow V, Lascher S, Mottur-Pilson C, et al. Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 2001; 134:595-599
17. Walsh EE, Falsey AR, Hennessey PA. Respiratory syncytial and other virus infection in persons with chronic cardio-pulmonary disease. Am J Respir Crit Care Med 1999; 160:791-795
18. Lieberman D. Atypical pathogens in community-acquired pneumonia. Clin Chest Med 1999; 20:489-497
19. von Hertzen L, Alakarppa H, Koskinen R, et al. Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease. Epidemiol Infect 1997; 118:155-164
20. Lieberman D, Schlaeffer F, Boldur I, et al. Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients. Thorax 1996; 51:179-184
21. Yi K, Sethi S, Murphy TF. Human immune response to nontypeable Haemophilus imfluenzae in chronic bronchitis. J Infect Dis 1997; 176:1247-1252
22. Murphy TF, Kirkham C, DeNardin E, et al. Analysis of antigenic structure and human immune response to outer membrane protein CD of Moraxella catarrhalis. Infect Immun 1999; 67:4578-4585
23. American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, initial antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163:1730-1754